Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: October 6, 2022

Details for New Drug Application (NDA): 019981

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 019981 describes ULTRATAG, which is a drug marketed by Curium and is included in one NDA. It is available from one supplier. Additional details are available on the ULTRATAG profile page.

The generic ingredient in ULTRATAG is technetium tc-99m red blood cell kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m red blood cell kit profile page.
Summary for 019981
Ingredient:technetium tc-99m red blood cell kit
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019981
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ULTRATAG technetium tc-99m red blood cell kit INJECTABLE;INJECTION 019981 NDA Curium US LLC 69945-068 69945-068-20 5 CELLO PACK in 1 BOX (69945-068-20) > 1 KIT in 1 CELLO PACK * .6 mL in 1 SYRINGE, GLASS * 1 mL in 1 SYRINGE, GLASS * 9.5 mg in 1 VIAL, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Jun 10, 1991TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.